How GLP-1 Policy Fits Into Trump’s Greenland Strategy, And 5 Other Health Tech Developments

What does a pharmaceutical company have to do with U.S. national security? Perhaps more than meets the eye, based on President Trump’s negotiating style, which often involves utilizing leverage to weaken the other side’s bargaining position. In the case at hand, President Trump has repeatedly expressed an interest in acquiring Greenland from Denmark for reasons involving national security.

Without knowing what those reasons are nor other special…